Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Summary

This is a multicenter open label non randomized phase II clinical trial of Weekly Cabazitaxel for Advanced Prostate Cancer in Hormone-Refractory Patients Previously Treated with Docetaxel. The purpose of this study is to evaluate the activity of the weekly administration of cabazitaxel as time to progression by PSA at week 12.

Timeline

Start

2012-05

Primary completion

2016-06

Completion

2016-07

Drugs

Indications